• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting: similarities and dissimilarities between North America and Europe.

作者信息

Huber Kurt, Airaksinen K Juhani, Cuisset Thomas, Marín Francisco, Rubboli Andrea, Lip Gregory Y H

出版信息

Thromb Haemost. 2011 Oct;106(4):569-71. doi: 10.1160/TH11-08-0602. Epub 2011 Sep 12.

DOI:10.1160/TH11-08-0602
PMID:21909592
Abstract
摘要

相似文献

1
Antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting: similarities and dissimilarities between North America and Europe.接受冠状动脉支架置入术的房颤患者的抗栓治疗：北美与欧洲的异同
Thromb Haemost. 2011 Oct;106(4):569-71. doi: 10.1160/TH11-08-0602. Epub 2011 Sep 12.
2
Consensus document: antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting. A North-American perspective.共识文件：接受冠状动脉支架置入术的心房颤动患者的抗血栓治疗。北美的观点。
Thromb Haemost. 2011 Oct;106(4):572-84. doi: 10.1160/TH11-04-0262. Epub 2011 Jul 25.
3
Triple antithrombotic therapy after coronary stenting in the elderly with atrial fibrillation: necessary or too hazardous?老年房颤患者冠状动脉支架置入术后的三联抗栓治疗：必要还是过于危险？
Am Heart J. 2012 Apr;163(4):531-4. doi: 10.1016/j.ahj.2012.01.018.
4
Dual antiplatelet therapy versus warfarin anticoagulation in patients undergoing catheter ablation of atrial fibrillation.房颤导管消融患者中双重抗血小板治疗与华法林抗凝治疗的比较
Int J Cardiol. 2014 May 1;173(2):345-6. doi: 10.1016/j.ijcard.2014.03.027. Epub 2014 Mar 15.
5
Anti-platelet pre-treatment for atrial fibrillation patients on warfarin referred for coronary angiography/stenting because of non-ST-elevation acute coronary syndrome: An alternative proposal.因非ST段抬高型急性冠状动脉综合征接受冠状动脉造影/支架置入术的房颤华法林治疗患者的抗血小板预处理：一项替代方案。
Int J Cardiol. 2015 Dec 15;201:494-6. doi: 10.1016/j.ijcard.2015.08.122. Epub 2015 Aug 17.
6
Warfarin and Antiplatelet Therapy Versus Warfarin Alone for Treating Patients With Atrial Fibrillation Undergoing Transcatheter Aortic Valve Replacement.华法林和抗血小板治疗与华法林单药治疗行经导管主动脉瓣置换术的心房颤动患者。
JACC Cardiovasc Interv. 2016 Aug 22;9(16):1706-17. doi: 10.1016/j.jcin.2016.06.025.
7
Bleeding complications of triple antithrombotic therapy after percutaneous coronary interventions.经皮冠状动脉介入治疗后三联抗栓治疗的出血并发症
Catheter Cardiovasc Interv. 2017 Feb 1;89(2):E64-E74. doi: 10.1002/ccd.26574. Epub 2016 May 24.
8
Triple antithrombotic therapy with aspirin, a thienopyridine derivative plus oral anticoagulation in patients with atrial fibrillation undergoing coronary stenting.阿司匹林、噻吩并吡啶衍生物与口服抗凝剂三联抗栓治疗用于接受冠状动脉支架置入术的房颤患者。
Hellenic J Cardiol. 2010 Jul-Aug;51(4):330-7.
9
Atrial fibrillation and acute myocardial infarction: antithrombotic therapy and outcomes.心房颤动和急性心肌梗死：抗血栓治疗与结局。
Am J Med. 2012 Sep;125(9):897-905. doi: 10.1016/j.amjmed.2012.04.006. Epub 2012 Jul 13.
10
Combining antiplatelet and antithrombotic therapy (triple therapy): what are the risks and benefits?联合抗血小板和抗血栓治疗（三联疗法）：风险与益处有哪些？
Am J Med. 2014 Jul;127(7):579-85. doi: 10.1016/j.amjmed.2014.02.030. Epub 2014 Mar 6.

引用本文的文献

1
Prevalence, Epidemiological Characteristics, and Pharmacotherapy of Coronary Artery Disease among Patients with Atrial Fibrillation: Data from Jo-Fib Study.房颤患者中心脏病的患病率、流行病学特征和药物治疗：来自 Jo-Fib 研究的数据。
Medicina (Kaunas). 2021 Jun 11;57(6):605. doi: 10.3390/medicina57060605.
2
Comparison of HAS-BLED with other risk models for predicting the bleeding risk in anticoagulated patients with atrial fibrillation: A PRISMA-compliant article.HAS - BLED与其他预测房颤抗凝患者出血风险模型的比较：一篇遵循PRISMA规范的文章。
Medicine (Baltimore). 2020 Jun 19;99(25):e20782. doi: 10.1097/MD.0000000000020782.
3
Left Atrial Appendage: Physiology, Pathology, and Role as a Therapeutic Target.
左心耳：生理学、病理学及其作为治疗靶点的作用
Biomed Res Int. 2015;2015:205013. doi: 10.1155/2015/205013. Epub 2015 Jul 7.
4
Non-VKA Oral Anticoagulants: Accurate Measurement of Plasma Drug Concentrations.非维生素K拮抗剂口服抗凝剂：血浆药物浓度的准确测量
Biomed Res Int. 2015;2015:345138. doi: 10.1155/2015/345138. Epub 2015 May 19.
5
Use of Anticoagulants and Antiplatelet Agents in Stable Outpatients with Coronary Artery Disease and Atrial Fibrillation. International CLARIFY Registry.抗凝剂和抗血小板药物在稳定型冠状动脉疾病合并心房颤动门诊患者中的应用。国际CLARIFY注册研究。
PLoS One. 2015 Apr 27;10(4):e0125164. doi: 10.1371/journal.pone.0125164. eCollection 2015.
6
Stroke and bleeding risk in atrial fibrillation: navigating the alphabet soup of risk-score acronyms (CHADS2 , CHA2 DS2 -VASc, R2 CHADS2 , HAS-BLED, ATRIA, and more).心房颤动的卒中与出血风险：解读风险评分首字母缩写的复杂体系（CHADS2、CHA2DS2-VASc、R2CHADS2、HAS-BLED、ATRIA等等）
Clin Cardiol. 2014 Oct;37(10):634-44. doi: 10.1002/clc.22294. Epub 2014 Aug 28.
7
Evolving antithrombotic strategies in patients with atrial fibrillation undergoing percutaneous coronary intervention: results from a survey among US cardiologists.接受经皮冠状动脉介入治疗的心房颤动患者不断发展的抗栓策略：美国心脏病专家的一项调查结果
Clin Cardiol. 2014 Feb;37(2):103-7. doi: 10.1002/clc.22226.
8
Use of novel oral anticoagulants in patients with heart failure.新型口服抗凝剂在心力衰竭患者中的应用。
Curr Treat Options Cardiovasc Med. 2014 Feb;16(2):285. doi: 10.1007/s11936-013-0285-y.
9
Oral antiplatelet therapy in acute coronary syndromes: update 2012.急性冠状动脉综合征的口服抗血小板治疗：2012 年更新。
Eur Heart J Acute Cardiovasc Care. 2012 Apr;1(1):79-86. doi: 10.1177/2048872612443345.
10
Warfarin use and long-term outcomes in patients with acute myocardial infarction and atrial fibrillation.急性心肌梗死合并心房颤动患者使用华法林及其长期预后
J Thromb Thrombolysis. 2014 Apr;37(3):331-7. doi: 10.1007/s11239-013-0946-4.